SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Jazz Pharmaceuticals at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
Jazz Pharmaceuticals brings 5 presentations to SNO 2026 in Philadelphia. Its program focuses on H3 K27M-mutant diffuse glioma, with industry-supported sessions on diagnosis and treatment. Research on its ClpP agonist in a phase 2 study also features.
| Organization | SNO 2026 Attendance |
|---|---|
Jazz Pharmaceuticals Dublin, Ireland | ◆Platinum Supporter |
A biopharmaceutical company developing and marketing medicines, including therapies used in neuro-oncology. | Talk Fri Nov 13 7–8:15am Poster Fri Nov 13 7:30–9:30pm Talk Sat Nov 14 7–8:15am Talk Sat Nov 14 3:19–3:24pm Session Sat Nov 14 6–7pm |
Find decision makers at Jazz Pharmaceuticals
Tell us what you sell and we’ll find the people at Jazz Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction